Thazolidinedione compounds
US5478853A · kind A · utility
24Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 20, 1995 |
| Grant date | Dec 26, 1995 |
| Priority date | — |
| Expiry date | Jan 20, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The compounds are 5-(4-substituted benzyl)thiazolidine-2,4-diones, enantiomers, diastereoisomers and pharmaceutically tolerable salts thereof, useful for treating conditions of insulin-resistance and/or non insulin-dependent diabetes. A compound disclosed is: 5-{4-[2-(2-methoxy-5-chlorobenzamido)ethyl]benzyl}thiazolidine-2,4-dione.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.